| 저자(한글) |
Kang, Gun,Lee, Yu Ran,Joo, Hee Kyoung,Park, Myoung Soo,Kim, Cuk-Seong,Choi, Sunga,Jeon, ByeongHwa |
| 저자(영문) |
|
| 소속기관 |
|
| 소속기관(영문) |
|
| 출판인 |
|
| 간행물 번호 |
|
| 발행연도 |
2015-01-01 |
| 초록 |
Histone deacetylase (HDAC) has been recognized as a potentially useful therapeutic target for cardiovascular disorders. However, the effect of the HDAC inhibitor, trichostatin A (TSA), on vasoreactivity and hypertension remains unknown. We performed aortic coarctation at the inter-renal level in rats in order to create a hypertensive rat model. Hypertension induced by abdominal aortic coarctation was significantly suppressed by chronic treatment with TSA (0.5 mg/kg/day for 7 days). Nicotinamide adenine dinucleotide phosphate-driven reactive oxygen species production was also reduced in the aortas of TSA-treated aortic coarctation rats. The vasoconstriction induced by angiotensin II (Ang II, 100 nM) was inhibited by TSA in both endothelium-intact and endothelium-denuded rat aortas, suggesting that TSA has mainly acted in vascular smooth muscle cells (VSMCs). In cultured rat aortic VSMCs, Ang II increased p66shc phosphorylation, which was inhibited by the Ang II receptor type I ( $AT_1R$ ) inhibitor, valsartan ( $10{ mu}M$ ), but not by the $AT_2R$ inhibitor, PD123319. TSA ( $1{ sim}10{ mu}M$ ) inhibited Ang II-induced p66shc phosphorylation in VSMCs and in HEK293T cells expressing $AT_1R$ . Taken together, these results suggest that TSA treatment inhibited vasoconstriction and hypertension via inhibition of Ang II-induced phosphorylation of p66shc through $AT_1R$ . |
| 원문URL |
http://click.ndsl.kr/servlet/OpenAPIDetailView?keyValue=03553784&target=NART&cn=JAKO201525257248655 |
| 첨부파일 |
|
